IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Lynx1 Capital Management LP

Q1 2023 Holdings

Filed 2023-05-15 | 13 holdings | $119.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Alpine Immune Sciences Inc(NVLSEUR)COM02083G100$24.2M3,136,17320.2%
Cabaletta BIO Inc(CABA)COM12674W109$20.3M2,454,62716.9%
Merus N VCOMN5749R100$19.6M1,067,72316.4%
Kinnate Biopharma IncCOM49705R105$13.8M2,214,25011.5%
Cymabay Therapeutics Inc(CBAYUSD)COM23257D103$11.9M1,369,92710.0%
Pieris Pharmaceuticals IncCOM720795103$6.9M7,067,7185.8%
Theseus Pharmaceuticals IncCOM88369M101$6.8M761,2585.6%
Bellus Health Inc New(BLU)COM NEW07987C204$6.2M866,6465.2%
Pardes Biosciences IncCOM69945Q105$4.4M3,324,0613.7%
Passage BIO IncCOM702712100$3.3M3,407,5982.7%
Neoleukin Therapeutics IncCOM64049K104$1.7M2,428,3231.4%
Structure Therapeutics Inc(GPCR)SPONSORED ADS86366E106$547.2K23,0000.5%
Pharvaris N V(PHVS)COMN69605108$211.2K26,2250.2%